Stockreport

Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results [Yahoo! Finance]

Guided Therapeutics Inc  (GTHP) 
NASDAQ:AMEX Investor Relations: guidedinc.com/investors
PDF Scan, announced today that a group of prominent cervical cancer doctors are in the final stages of completing the clinical data report that will be submitted for approva [Read more]